Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.

about

Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.

Item

http://www.wikidata.org/entity/Q55642764

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@en

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@nl

type

Item

label

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@en

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@nl

prefLabel

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@en

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@nl

P1476

Biochemical Properties of a De ...... of STAT3 Transcription Factor.

@en

P2093

Daniel E Johnson

http://www.w3.org/2001/XMLSchema#string

David S Lee

http://www.w3.org/2001/XMLSchema#string

Patrick K Ha

http://www.w3.org/2001/XMLSchema#string

Rachel A O'Keefe

http://www.w3.org/2001/XMLSchema#string

P2860

STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

STATs in cancer inflammation and immunity: a leading role for STAT3

The STATs of cancer--new molecular targets come of age

Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

STAT3 signaling: anticancer strategies and challenges.

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.

P31

scholarly article

P356

10.3390/IJMS19061608

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Grandis

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29848966

http://www.w3.org/2001/XMLSchema#string

P932

6032396

http://www.w3.org/2001/XMLSchema#string